ELVT · Elevate Credit, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $125.62M | $117.61M | $124.24M | - | $112.83M | $84.54M | $89.73M | - | $94.16M | $117.99M |
| Cost of Revenue | $81.76M | $72.45M | $93.27M | - | $75.08M | $40.69M | $27.40M | - | $17.42M | $43.43M |
| Gross Profit | $43.86M | $45.16M | $30.98M | - | $37.76M | $43.85M | $62.33M | - | $76.74M | $74.56M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $35.02M | $39.87M | $38.28M | - | $40.87M | $38.61M | $37.59M | - | $42.66M | $36.50M |
| D&A | $4.52M | $4.72M | $3.76M | - | $4.54M | $4.55M | $5.24M | - | $4.59M | $4.53M |
| Operating Income | $8.84M | $5.29M | ($7.30M) | - | ($3.11M) | $5.24M | $24.74M | - | $34.08M | $38.06M |
| Interest Expense | $13.65M | $12.13M | $12.17M | - | $9.54M | $8.57M | $8.79M | - | $11.57M | $12.18M |
| Income Tax | $9.86M | ($574.0K) | ($4.23M) | - | ($1.84M) | $228.0K | $3.44M | - | $4.88M | $8.37M |
| Net Income | ($15.03M) | ($6.54M) | ($13.92M) | - | ($11.01M) | ($3.04M) | $12.72M | - | $21.08M | $8.55M |
| EPS - Basic | ($0.48) | ($0.21) | ($0.44) | - | ($0.33) | ($0.09) | $0.35 | - | $0.52 | $0.20 |
| EPS - Diluted | ($0.48) | ($0.21) | ($0.44) | - | ($0.33) | ($0.09) | $0.34 | - | $0.52 | $0.20 |
Balance Sheet
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72.60M | $73.96M | $105.81M | $84.98M | $79.98M | $105.78M | $140.30M | $197.98M | $224.26M | $167.74M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $789.22M | $782.01M | $779.50M | $710.68M | $655.88M | $574.73M | $564.34M | $669.60M | $664.36M | $639.67M |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $560.57M | $515.98M | $503.25M | $505.28M | $435.82M | $351.21M | $341.04M | $438.40M | $438.20M | $438.17M |
| Total Liabilities | $620.06M | $597.07M | $588.50M | $601.71M | $513.57M | $417.08M | $397.37M | $505.74M | $492.85M | $483.54M |
| Stockholders' Equity | $169.16M | $184.94M | $191.00M | $108.97M | $142.32M | $157.65M | $166.97M | $163.86M | $171.51M | $156.13M |
| Retained Earnings | $4.00M | $21.32M | $28.77M | ($55.16M) | ($22.80M) | ($11.78M) | ($8.05M) | ($20.10M) | ($13.93M) | ($34.12M) |
Cash Flow
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $49.94M | - | - | - | $31.88M | - | - | - |
| Investing Cash Flow | - | - | ($24.20M) | - | - | - | $19.09M | - | - | - |
| Financing Cash Flow | - | - | ($6.23M) | - | - | - | ($108.75M) | - | - | - |
| CapEx | - | - | $6.28M | - | - | - | $3.38M | - | - | - |
| Free Cash Flow | - | - | $43.66M | - | - | - | $28.50M | - | - | - |
Ratios
| Metric | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 34.9% | 38.4% | 24.9% | - | 33.5% | 51.9% | 69.5% | - | 81.5% | 63.2% |
| Operating margin | 7.0% | 4.5% | -5.9% | - | -2.8% | 6.2% | 27.6% | - | 36.2% | 32.3% |
| EBITDA margin | 10.6% | 8.5% | -2.9% | - | 1.3% | 11.6% | 33.4% | - | 41.1% | 36.1% |
| Net margin | -12.0% | -5.6% | -11.2% | - | -9.8% | -3.6% | 14.2% | - | 22.4% | 7.2% |
| Free cash flow margin | - | - | 35.1% | - | - | - | 31.8% | - | - | - |
| FCF / Net income | - | - | -3.14 | - | - | - | 2.24 | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | 21.3% | - | 18.8% | 49.5% |
| Return on assets | -1.9% | -0.8% | -1.8% | - | -1.7% | -0.5% | 2.3% | - | 3.2% | 1.3% |
| Return on equity | -8.9% | -3.5% | -7.3% | - | -7.7% | -1.9% | 7.6% | - | 12.3% | 5.5% |
| Return on invested capital | 1.0% | 0.6% | -0.8% | - | -0.4% | 0.8% | 3.8% | - | 4.5% | 3.2% |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 3.31 | 2.79 | 2.63 | 4.64 | 3.06 | 2.23 | 2.04 | 2.68 | 2.55 | 2.81 |
| Debt / Assets | 0.71 | 0.66 | 0.65 | 0.71 | 0.66 | 0.61 | 0.60 | 0.65 | 0.66 | 0.68 |
| Debt / EBITDA | 41.96 | 51.53 | - | - | 303.07 | 35.87 | 11.37 | - | 11.33 | 10.29 |
| Interest coverage | 0.6x | 0.4x | -0.6x | - | -0.3x | 0.6x | 2.8x | - | 2.9x | 3.1x |
| Equity multiplier | 4.67 | 4.23 | 4.08 | 6.52 | 4.61 | 3.65 | 3.38 | 4.09 | 3.87 | 4.10 |
| Liabilities / Assets | 0.79 | 0.76 | 0.75 | 0.85 | 0.78 | 0.73 | 0.70 | 0.76 | 0.74 | 0.76 |
| Efficiency | ||||||||||
| Asset turnover | 0.16 | 0.15 | 0.16 | - | 0.17 | 0.15 | 0.16 | - | 0.14 | 0.18 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 11.3% | 39.1% | 38.5% | - | 19.8% | -28.4% | -49.4% | - | -51.2% | -33.6% |
| Revenue CAGR (3y) | -13.3% | -12.9% | -13.1% | - | -17.6% | -17.5% | -22.6% | - | -15.1% | -2.4% |
| Revenue CAGR (5y) | -4.0% | -1.5% | -1.0% | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 16.2% | 3.0% | -50.3% | - | -50.8% | -41.2% | -16.1% | - | 8.9% | -0.6% |
| Operating income growth (YoY) | - | 1.0% | - | - | - | -86.2% | -3.7% | - | 52.6% | 40.7% |
| Net income growth (YoY) | -36.6% | -114.9% | - | - | - | - | - | - | 342.5% | 48.2% |
| EPS growth (YoY) | -45.5% | -133.3% | - | - | - | - | - | - | 372.7% | 53.8% |
| EPS CAGR (3y) | - | - | - | - | - | - | 15.6% | - | 273.3% | 35.7% |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | 53.2% | - | - | - | -59.9% | - | - | - |
| FCF CAGR (5y) | - | - | -4.7% | - | - | - | - | - | - | - |
| Book value growth (YoY) | 18.9% | 17.3% | 14.4% | -33.5% | -17.0% | 1.0% | 13.0% | 4.7% | 17.7% | 11.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$4.09M totalProduct And Service Other$4.09M · 100.0%
Peer comparison
Same SIC group: Finance Services
Comparing Elevate Credit against the 5 most active filers in the same SIC group.